Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status

The clinical benefit of anthracyclines has been connected to HER2 status, TOP2A status and centromere 17 copy numbers (CEN‐17). Data from a clinical trial randomizing patients to anthracyclines was used to assess whether the number of CEN‐17 in breast cancers may predict incremental responsiveness t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Oncol
Hlavní autoři: Nielsen, Kirsten Vang, Ejlertsen, Bent, Møller, Susanne, Jensen, Maj-Britt, Balslev, Eva, Müller, Sven, Knoop, Ann, Mouridsen, Henning T.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2011
Témata:
Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528381/
https://ncbi.nlm.nih.gov/pubmed/22153616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2011.11.006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky